Roger Garceau - Jan 1, 2022 Form 3 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Stock symbol
ENTX
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3
Date filed
1/11/2022, 03:01 PM
Previous filing
Jun 10, 2021
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 4.94K Jan 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENTX Stock Option (right to buy) Jan 1, 2022 Ordinary Shares, par value NIS 0.0000769 per share 147K $3.69 Direct
holding ENTX Stock Option (right to buy) Jan 1, 2022 Ordinary Shares, par value NIS 0.0000769 per share 209K $6.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vested on a monthly basis over a three-year period that commenced January 1, 2017.

Remarks:

See Exhibit 24.1 - Power of Attorney